Acta Diabetol 60(9):12571266 Berra C, Manfrini R, Bifari F, Cipponeri E, Ghelardi R, Centofanti L et al (2024) Improved glycemic and weight control with dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting
The question of whether GLP-1 medications like semaglutide require lifelong use has become central to weight loss discussions
The prolonged exposure of renal cells to oxidative damage impairs the ability of the tubules to transport, absorb, and excrete electrolytes and water, and leads to fibrosis and loss of kidney function
Theyll also complete daily check-ins to reflect on patterns and progress, read daily lessons to understand the importance of nutrition during periods of rapid weight loss, and receive daily tips to optimize how they eat, sleep, and move
44-84 10 L.A